30 results
8-K
EX-1.1
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm
Entity, against or affecting the Company relating to Hazardous Materials or any Environmental Laws.
(xxvi) Health Care Laws. Except where instances … as may be required by the FDA or any committee thereof, any other U.S. or foreign government drug or biological product regulatory agency, or health care facility
S-3
EX-1.2
hamyw7
1 Jul 22
Shelf registration
5:06pm
10-K
sodhkhdxt5ry
28 Mar 22
Annual report
4:51pm
10-K
EX-10.7
gvdz772bzzfty h3qx3
28 Mar 22
Annual report
4:51pm
10-K
EX-10.8
00b0hnw8uf
28 Mar 22
Annual report
4:51pm
10-K
EX-10.9
i1tp37 epl
28 Mar 22
Annual report
4:51pm
10-K
EX-10.10
ftzhwpxw6yuj8
28 Mar 22
Annual report
4:51pm
10-Q
0a00mw8o qt14
16 Aug 21
Quarterly report
4:51pm
10-Q
EX-10.8
7ethq8ru
16 Aug 21
Quarterly report
4:51pm
424B4
y6zux7 fs
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.1
d0feqmjunosf06hl1i
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
bc2dv89v3naq7f0ozd3r
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-1.1
ljt867x6
24 Jun 21
IPO registration (amended)
8:17am
S-1
EX-10.9
wk0t6 nfsygvwr3pc4g
9 Jun 21
IPO registration
5:02pm